Skip to content

Clinical trials

Completed Small Cell Lung Carcinoma trials in South Korea

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Small Cell Lung Carcinoma Status: Completed Country / region: South Korea Clear all

42 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20031
20051
20063
20081
20094
20102
20112
20122
20142
20152
20164
20174
20185
20191
20204
20212
20221

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed42

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AbbVie4
Eli Lilly and Company4
GlaxoSmithKline4
Hoffmann-La Roche4
Samsung Medical Center4
National Cancer Center, Korea3
AstraZeneca2
Bristol-Myers Squibb2
Merck Sharp & Dohme LLC2
Se-Hoon Lee2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Small Cell Lung Carcinoma42
Carcinoma, Non-Small-Cell Lung4
Lung Neoplasms3
Neoplasms3
Breast Neoplasms2
Esophageal Squamous Cell Carcinoma2
Neoplasm Metastasis2
Ovarian Neoplasms2
Squamous Cell Carcinoma of Head and Neck2
Stomach Neoplasms2

Trials

Showing 1 to 25 of 42. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.